Mushroom World team Verified: November 15, 2026 ~3 min read

Mushrooms and the gut microbiome: how fungal chitin and beta-glucans work in humans

Why fungal cell walls — chitin and branched beta-glucans — resist upper-GI digestion and feed colonic bacteria: a review of three human clinical trials.

#microbiome#nutrition#fiber#beta-glucans#research

Unlike plants, fungi do not build their cell walls out of cellulose. Instead, their structural scaffold is made of chitin (the same polymer found in crustacean shells and insect exoskeletons) interwoven with branched beta-1,3/1,6-glucans. Human digestive enzymes barely touch this architecture. Yet what escapes digestion in the small intestine is not wasted: it reaches the colon intact and serves as substrate for resident gut bacteria.

Biological accuracy matters here: culinary mushrooms do not colonize the gut like live probiotics. Rather, they act as prebiotics — a distinct structural fiber matrix metabolized by our own microbial community. Three human clinical studies show what actually happens.

Study 1: everyday button mushrooms vs meat (Hess & Slavin, 2018)

Researchers at the University of Minnesota ran a randomized crossover trial in 32 healthy adults (study card, Nutrients, 2018, PMID 30279332). Each participant completed two 10-day phases: whole button mushrooms twice daily versus a protein-matched meat diet.

Key measurements:

  • Microbiota shift: the mushroom phase produced a higher proportion of Bacteroidetes (p = 0.0002) and lower Firmicutes (p = 0.0009) compared with meat.
  • Bowel function: stool weight was significantly higher on mushrooms (p = 0.002), consistent with unabsorbed fungal fiber supporting laxation.
  • No shortcuts: short-chain fatty acids (SCFAs) and stool pH did not change over 10 days, and participants reported more mild GI symptoms during the first two days — a common response to a sudden fiber increase.

Study 2: shiitake beta-glucan extract (Morales et al., 2021)

In Madrid, an 8-week double-blind, placebo-controlled trial enrolled 52 adults with untreated mild hypercholesterolemia (Reducol trial, NCT03550287; study card, Eur J Nutr, 2021, PMID 33580297). Participants consumed a shiitake extract delivering 3.5 g/day of fungal beta-glucans or placebo.

The primary hypothesis — lowering blood lipids and inflammatory cytokines (IL-1β, IL-6, TNF-α) — did not pan out. However, the intervention safely raised total fiber intake to cardioprotective levels and differentially modulated colonic microbiota compared with placebo, with specific bacterial genera correlating with cholesterol metabolism markers.

Study 3: response depends on baseline microbiota (Hatayama et al., 2025)

A more nuanced picture emerged from a 2025 Japanese intervention in 170 older adults aged 60–79 (study card, Frontiers in Nutrition, PMID 40761356). Over 8 weeks, participants ate granulated golden oyster mushroom (tamogitake), moringa leaves or rice bran, alongside 16S microbiota sequencing and Cognitrax cognitive testing.

The same mushroom did not act identically in everyone. Among cognitive "responders", bacteria linked in the literature to butyrate production and healthy aging (Faecalibacterium, Blautia, Parabacteroides) shifted distinctly, whereas non-responders showed different baseline profiles. The authors' conclusion respects individual biology: effectiveness depends on matching a food to a person's existing gut ecosystem.

Practical takeaways

  1. Mushrooms supply a fiber type plants lack. Most adults fall short on dietary fiber; button, oyster and shiitake mushrooms contribute chitin and branched beta-glucans absent from grains and vegetables.
  2. Increase portions gradually. As Hess 2018 showed, jumping straight to large mushroom servings can cause temporary bloating for 1–2 days while the microbiota adapts.
  3. Always cook culinary mushrooms. Heat breaks down heat-labile compounds and softens the chitin matrix, improving both safety and digestive comfort.

Limits of knowledge

  • Ten-day trials capture rapid compositional shifts, but long-term stability over months remains under-studied.
  • Shifts in broad bacterial phyla (Bacteroidetes/Firmicutes) are biological markers of ecosystem adaptation, not direct proof of disease treatment.

Sources

  1. Nutrients 2018: Agaricus bisporus and gut health markers, crossover RCT n=32 (PMID 30279332)
  2. European Journal of Nutrition 2021: shiitake beta-D-glucan extract and microbiota, RCT n=52 (PMID 33580297)
  3. Frontiers in Nutrition 2025: tamogitake food intervention, microbiota and cognition, n=170 (PMID 40761356)